In our opinion this news is not new and should not slow down the merger with Guidant.

The good news is that this is not a recall, products are not being removed from hospital shelves, and no one has died.

There's a phrase: to strike while the iron is hot. The iron is hot.

They're certainly making it harder for J&J to come back. Strategically we believe Boston Scientific with Guidant is a better match.

I think J&J has a claim. I don't think they are going to have to pay Guidant.

You know where you stand with him. Nothing is candy-coated.